GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » EV-to-EBITDA

Moss Genomics (XCNQ:MOSS) EV-to-EBITDA : -4.83 (As of Jun. 22, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Moss Genomics's enterprise value is C$0.87 Mil. Moss Genomics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.18 Mil. Therefore, Moss Genomics's EV-to-EBITDA for today is -4.83.

The historical rank and industry rank for Moss Genomics's EV-to-EBITDA or its related term are showing as below:

XCNQ:MOSS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -84.9   Med: 0   Max: 0
Current: -4.83

XCNQ:MOSS's EV-to-EBITDA is ranked worse than
100% of 466 companies
in the Healthcare Providers & Services industry
Industry Median: 12.69 vs XCNQ:MOSS: -4.83

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), Moss Genomics's stock price is C$0.02. Moss Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.012. Therefore, Moss Genomics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Moss Genomics EV-to-EBITDA Historical Data

The historical data trend for Moss Genomics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics EV-to-EBITDA Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
EV-to-EBITDA
- -7.12

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.71 -7.12 -6.93 -6.50 -4.83

Competitive Comparison of Moss Genomics's EV-to-EBITDA

For the Health Information Services subindustry, Moss Genomics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moss Genomics's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Moss Genomics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Moss Genomics's EV-to-EBITDA falls into.



Moss Genomics EV-to-EBITDA Calculation

Moss Genomics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.874/-0.181
=-4.83

Moss Genomics's current Enterprise Value is C$0.87 Mil.
Moss Genomics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moss Genomics  (XCNQ:MOSS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Moss Genomics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.02/-0.012
=At Loss

Moss Genomics's share price for today is C$0.02.
Moss Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.012.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Moss Genomics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Moss Genomics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics (XCNQ:MOSS) Business Description

Traded in Other Exchanges
N/A
Address
1030 West Georgia Street, Suite 907, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that offers personalized health, antiaging and wellness offerings guided by genomic, microbiome, and epigenome data. The Company intends to eliminate barriers in healthcare by offering easy-access, at-home, affordable testing paired with easy-to-understand actionable results.

Moss Genomics (XCNQ:MOSS) Headlines

No Headlines